75702-85-1 Usage
Chemical class
Pyrazole
Structure
Contains a pyrazole ring with an attached ethyl group and a hydroxyl group
Organic compound
Yes
Applications
a. Synthesis of pharmaceuticals
b. Synthesis of agrochemicals
c. Building block for other organic compounds
Biological activities studied
a. Anti-inflammatory properties
b. Analgesic properties
Versatility
High, due to its structure and properties
Industrial and pharmaceutical uses
Potential for various applications
These properties and contents provide a comprehensive overview of 1-ETHYL-1H-PYRAZOL-4-OL, highlighting its chemical structure, applications, and potential for further research and development in the fields of pharmaceuticals and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 75702-85-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,5,7,0 and 2 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 75702-85:
(7*7)+(6*5)+(5*7)+(4*0)+(3*2)+(2*8)+(1*5)=141
141 % 10 = 1
So 75702-85-1 is a valid CAS Registry Number.
75702-85-1Relevant articles and documents
PESTICIDALLY-ACTIVE CYANAMIDE HETEROCYCLIC COMPOUNDS
-
Page/Page column 84-85, (2020/09/08)
A compound of formula (I), wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, can be used as insecticides.
HISTONE DEMETHYLASE INHIBITORS
-
, (2014/10/04)
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted pyrido[3,4-d]pyrimidin-4-one derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like
